StemCells to Present at Investment and Scientific Conference
PALO ALTO, Calif.--(BUSINESS WIRE)--Oct. 13, 2004--StemCells, Inc.
(NASDAQ:STEM) today announced that senior management will be
presenting at the Rodman & Renshaw Techvest 6th Annual Healthcare
Conference and Strategic Research Institute's (SRI) 4th Annual Stem
Cells & Regenerative Medicine Conference.
Martin McGlynn, president and CEO, will speak at the Rodman &
Renshaw Techvest Annual Healthcare Conference on Wednesday, October 27
at 1:15 p.m. Eastern Time. A live audio webcast of the conference
presentation will be available on the Investor Relations portion of
StemCells' Web site, www.stemcellsinc.com, with a replay available for
14 days. The conference will be held at the Waldorf Astoria, New York.
To request additional information or to register, visit
www.rodmanandrenshaw.com.
Ann Tsukamoto, Ph.D., VP, Research and Development, will present
at the SRI Stem Cells & Regenerative Medicine Conference, speaking on
Human CNS Stem Cells: Moving to the Clinic, on Tuesday, October 19 at
9:15 a.m. Eastern Time. The conference will be held at the Westin
Princeton at Forrestal Village, Princeton, New Jersey. For additional
information, or to register for the conference, visit
www.srinstitute.com/CS309.
#########################
CONTACT: StemCells, Inc.
Martin McGlynn, 650-475-3100
or
Lippert/Heilshorn & Associates (Investor Relations)
Ina McGuinness or Bruce Voss, 310-691-7100
imcguinness@lhai.com
SOURCE: StemCells, Inc.
|
